Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 173 for “"Cancer Genomics"”.
-
Topics in cancer genomics
<p>Large-scale projects such as the The Cancer Genome Atlas (TCGA) have generated extensive exome libraries across several disease types and populations. Detection of somatic changes in HLA genes by whole-exome sequencing (WES) has been complicated by the highly polymorphic nature of these loci. We …
-
Algorithms for infection and cancer genomics
The student, Palash Sashittal, submitted this Thesis for approval on 2021-07-19 at 11:33.
-
Computational methods for personalized cancer genomics
In recent years, cancer treatment strategies have moved towards personalized approaches, specifically tailoring cancer treatments on a single-patient basis using molecular profiles from the patients’ tumor genomes. Knowledge of a patient’s molecular profile can be used to 1) identify the disease …
-
A Cloud-Based Infrastructure for Cancer Genomics
… analysis has now become the central challenge in genomics. </p><p>NGS has provided rich tools for defining genomic alterations that cause cancer. The processing time and computing requirements have now become a serious bottleneck to the characterization and analysis of these genomic alterations. …
-
NOVEL COMPUTATIONAL METHODS FOR CANCER GENOMICS DATA ANALYSIS
Cancer is a genetic disease responsible for one in eight deaths worldwide. The advancement of next-generation sequencing (NGS) technology has revolutionized the cancer research, allowing comprehensively profiling the cancer genome at great resolution. Large-scale cancer genomics research has …
-
Novel Biology-driven bioinformatics methods in Cancer genomics
… blooming fields for microarray application is cancer research. Despite the promising nature of these initial microarray studies, such conventional approaches are associated with certain limitations. Because of these challenges, it is important to develop new methods to mine the inherent …
-
Novel machine learning for applications in cancer genomics
Genomics has advanced rapidly in the past decade, with whole-genome sequencing and single-cell RNA sequencing now routine in cancer research. Machine and deep learning have also taken off, but applying them to biology remains challenging due to confounding factors, irregularly distributed data, and …
-
The Molecular Associations of Host Characteristics in Cancer Genomics
… studies have identified myriad differences in cancer burden between people of different sexes, ancestries, and ages. Male individuals are more likely to develop most cancers and die of their disease. While overall cancer incidence is comparable between individuals of African vs. European …
-
Bayesian Kernel Models for Statistical Genetics and Cancer Genomics
… trait loci (QTL) mapping studies, and cancer biology association studies. Lastly, we will also explore the potential of these approaches in radiogenomics, a brand new subfield of genetics and genomics that focuses on the study of correlations between imaging or network features and …
-
Statistical Approaches to Identifying Therapeutic Vulnerabilities from Cancer Genomics Data
… the growing prevalence of genomically targeted cancer therapies. However, durable responses to these therapies are rarely achieved in the majority of cancers due to cancer cells’ resistance to therapy. There is a significant challenge in identifying which patients will benefit from targeted …
-
Relatedness inference, pedigree reconstruction, and cancer genomics in large cohorts.
As the cost of collecting genetic information decreases, and the size of available genetic datasets increases, tools that efficiently process these datasets become more important. Our goal is to develop multiple algorithms that can extract useful quantities from these large datasets to inform …
-
Leveraging Cancer Genomics to Answer Clinically Motivated Questions: A Statistical Perspective
Cancer is the number two cause of mortality in New Zealand. Up until the late 1990s there was a concerted effort by drug companies to develop 'blockbuster' therapies for the treatment of cancer, that is cancer therapies developed with a one-size-fits-all approach. This philosophy was upended by the …
-
A holistic understanding of cancer genomics to inform treatment and research
Background: The increase in volume of cancer genomic data has improved our understanding of cancer biology as well as laying the foundation for clinical precision oncology. The main limitation in this field now sits within the analytical methods, rather than data generation. Currently, there is no …
-
Statistical Methods for Improving Low Frequency Variant Calling in Cancer Genomics
Cancer is not a single disease, but a family of genomic diseases characterized by a set of initiating genomic variants accumulated in a single cell that allows that cell to begin dividing uncontrollably. Tumors grow by cell division, and each cell division generates a new set of variants that are …
-
Development of Cancer-Genomics-Guided Precision Immunotherapy for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which accounts for 15-20% of all breast cancers, is highly aggressive and metastatic with the poorest overall rates. While surgery, radiation, and chemotherapy remain the main treatment options, TNBC represents an unmet medical need for better treatment …
-
Graph-based Approaches for Cancer Genomics, with Applications to Cancer Signaling and Dependencies
… graph-based approaches to evaluate their use in cancer genomics. We first focused on a graph-based semi-supervised learning approach called label propagation as a method to generate signaling networks from a gene set of interest. A distance metric based on the concept of maximal common subgraph …
-
Bioinformatics and cancer genomics approaches to advance precision medicine and elucidate tumor mutational landscapes
… by in-depth analyses which characterize the pan-cancer landscape of splice-associated mutations and noncoding, regulatory mutations across multiple subtypes of breast cancer. In Chapters 2 and 3, substantial efforts were made to update the content and the user experience for the drug-gene …
Page 1 of 9